TP53 and ovarian cancer: In this study, p53 activation by doxorubicin caused an up-regulation of miR-145 and a down-regulation of MTDH in ovarian cancer cells (Figure 7A and 7B), which is consistent with the idea that down-regulation of miR-145 may be caused by p53 mutation in HGSOC.